fbpx

About

MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on proprietary genetic, epigenetic and other complex molecular technologies.

MDxHealth is dedicated to providing highly accurate and clinically actionable urologic solutions to inform patient diagnosis and treatment while improving healthcare economics for payers and providers.

Working With MDxHealth

MDxHealth seeks talented people who are passionate about improving the diagnosis and treatment of cancer patients.

Leadership

Michael K. McGarrity

Chief Executive Officer, Director

Ron Kalfus

Chief Financial Officer

John Bellano

Chief Commercial Officer

Miriam Reyes

Executive Vice President of Operations

Joseph Sollee

Executive Vice President of Corporate Development and General Counsel

Board of Directors

Koen Hoffman

Chairman and Independent Director

Eric Bednarski, Ph.D

Director

Rudi Mariën

Director, representing Biovest CVA

Michael K. McGarrity

Chief Executive Officer, Director

Jan Pensaert

Director, representing Valiance Advisors LLP

Regine Slagmulder

Independent Director, representing Regine Slagmulder BV

Lieve Verplancke MD.

Independent Director, representing Qaly-Co BVBA

Hilde Windels

Independent Director, representing Hilde Windels BVBA

Clinical Research Network

MDxHealth collaborates with a large number of international academic institutes, medical centers and organizations:

Licensure & Accreditations

MDxHealth endeavors to meet and exceed industry standards for clinical laboratory testing.

Careers

MDxHealth seeks talented people who are passionate about improving the diagnosis and treatment of cancer patients.

Contact Us

Please contact us with questions or to learn more about our molecular diagnostic solutions and the real-world studies that prove their effectiveness.